Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Towards FnB is a South Korean healthcare company specializing in the development and commercialization of medical foods, often referred to as "Medi-food," for patients with specific clinical nutritional needs. The company focuses on providing specialized dietary solutions for individuals suffering from dysphagia, diabetes, and chronic kidney disease. By utilizing advanced food processing technologies, Towards FnB creates texture-modified and nutrient-balanced meals that are both safe and effective for elderly and chronically ill populations. Their business model includes a personalized nutrition platform that tailors food products to the specific medical requirements of individual patients. The company's products are designed to improve patient outcomes and quality of life by addressing malnutrition and dietary restrictions in clinical settings. Towards FnB is currently expanding its reach within the domestic Korean market and exploring international opportunities in the growing medical nutrition sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Towards FnB.